药物对比
Rosiglitazone vs Insulin Icodec
比较Rosiglitazone与Insulin Icodec治疗2型糖尿病。口服胰岛素增敏剂 vs 每周一次基础胰岛素：疗效、安全性及给药方面的差异。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when type 2 diabetes patients consider switching from oral sensitizers to weekly insulin therapy.
结论
Rosiglitazone suits early insulin-resistant type 2 diabetes as a daily pill while Insulin Icodec benefits those needing basal insulin with weekly dosing.
全部药物对比